Загрузка...
CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses
Despite the well-established antitumor activity of CD1d-restricted invariant natural killer T lymphocytes (iNKT), their use for cancer therapy has remained challenging. This appears to be due to their strong but short-lived activation followed by long-term anergy after a single administration of the...
Сохранить в:
| Главные авторы: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer-Verlag
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3624007/ https://ncbi.nlm.nih.gov/pubmed/23242316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-012-1381-7 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|